Loading company…
Riskpilot
← Back to search
Sign in
Get full access
David Anderbergs läkarkonsult AB
AB
Active
Org 5593999385
Lägatan 21
General medical practice activities · NACE 8621
Est. 2022
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 38K
-74% vs 2024
EBITDA margin
-7.1%
-124% vs 2024
Equity ratio
90.0%
Financial strength
Net profit 2025
SEK -3K
-125% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 38K
-74%
EBITDA
SEK -3K
-124%
Net profit
SEK -3K
-125%
Total assets
SEK 25K
-65%
Equity
SEK 22K
-36%
Employees
0
—
Company information
Legal name
David Anderbergs läkarkonsult AB
Org number
5593999385
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 oktober 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är konsultverksamhet inom sjukvård, äga och förvalta fastigheter och värdepapper samt därmed förenlig verksamhet.
Contact
Address
Lägatan 21
Email
cdanderberg@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Malmö
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
99
144
38
Staff expenses
−4
−105
−24
EBITDA
87
11
−3
Depreciation & amort.
—
—
—
EBIT
87
11
−3
Net financials
1
1
0
Profit before tax
88
12
−3
Tax
−18
−2
—
Net profit
70
10
−3
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
125
71
25
Equity
95
35
22
Long-term debt
—
—
—
Short-term debt
30
36
2
Total debt
30
36
2
Financial ratios
5-year trend
EBITDA margin
-7.1%
This company
15.8%
Market median
-145% vs market
2023
2025
Equity ratio
90.0%
This company
38.2%
Market median
+136% vs market
2023
2025
Return on equity
-11.4%
This company
18.4%
Market median
-162% vs market
2023
2025
Net profit margin
-6.8%
This company
8.1%
Market median
-184% vs market
2023
2025
Asset turnover
1.51×
This company
1.12×
Market median
+35% vs market
2023
2025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-10-04 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
CD
Carl David Anderberg
Board of Directors
2022
CT
Carl Theodor Mörse Anderberg
Deputy Board Member
2026
Former (1)
LA
Leif-Göran Anderberg
Deputy Board Member
2022 – 2026
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of David Anderbergs läkarkonsult AB also hold positions in
0
other companies.
Person
Role here
Other companies
Carl David Anderberg
Board of Directors
0 companies
Carl Theodor Mörse Anderberg
Deputy Board Member
0 companies
Leif-Göran Anderberg
Deputy Board Member
0 companies